SecBot SecBot
8-K ·Filed Jul 14, 2026

ANIK

Anika Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001171843-26-004635
Actionable Insight • Neutral

The extended credit facility removes near-term refinancing risk and provides committed liquidity through 2031. Monitor upcoming quarterly filings for leverage ratio and covenant compliance, as the reduced facility size may signal conservative capital management. No immediate catalyst for stock movement.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$15.93
T+0 close · Jul 14, 2026 · via day close
Latest settled
+20.72%
T+60 · $19.23
Vs SPY
+18.18%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $15.93entry
  2. T+1 · 4mo ago −0.69%α −0.15% · $15.82
  3. T+5 · 4mo ago −5.78%α −4.79% · $15.01
  4. T+20 · 3mo ago +38.29%α +35.95% · $22.03
  5. T+60 · 6w ago +20.72%α +18.18% · $19.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Anika Therapeutics entered into a Fifth Amendment to its existing credit agreement with Bank of America on July 10, 2026, reducing the revolving facility to $50 million and extending the maturity to July 10, 2031. The amendment includes a potential $50 million accordion feature, SOFR-based pricing with a spread of 0.25%-1.25%, and financial covenants (max leverage 3.50x, min interest coverage 3.00x). This is a routine refinancing that provides extended liquidity without material new financial data.

Key Facts

  • Revolving credit facility reduced to $50 million (from an undisclosed prior amount) with a maturity date of July 10, 2031.
  • Company may request up to an additional $50 million in commitments, subject to lender approval, for a maximum of $100 million.
  • Interest rate is SOFR plus 0.25% to 1.25% based on consolidated leverage ratio; commitment fee is 0.20% to 0.30% per annum.
  • Financial covenants: maximum Consolidated Net Leverage Ratio of 3.50x (stepping to 4.00x for material acquisitions) and minimum Consolidated Interest Coverage Ratio of 3.00x.
  • Lenders hold a first-priority lien on substantially all assets of the company.

Financial Impact

No new borrowing or financial figures disclosed; facility size reduced to $50 million with extended maturity.

debtliquidity

Risk Factors

  • Potential covenant breach if leverage increases above 3.50x or interest coverage falls below 3.00x.
  • Interest rate exposure from SOFR-based floating rate pricing.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (ANIK), Batch item 10001171843-26-004635
Exhibit: exh_102.htm0001171843-26-004635
Document: f8k_071426.htm0001171843-26-004635
Document: 0001171843-26-004635-index-headers.html0001171843-26-004635
Document: 0001171843-26-004635-index.html0001171843-26-004635
Document: 0001171843-26-004635.txt0001171843-26-004635
8-K Filing (ANIK), Batch item 70001171843-26-004635

Track record

13 reports on ANIK

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 6, 202610d ago 8-K Mixed 6/10 Entry $14.55 Now $12.92 −11.20% settles Feb 4
  2. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $21.42 Now $12.92 −39.68% settles Jan 21
  3. Jul 29, 202615w ago 8-K Bullish 8/10 Entry $16.17 to $21.09 Now $12.92 −20.10% ▲ +30.43% +25.70% vs SPY
  4. Jul 14, 202617w ago 8-K Neutral 3/10 Viewing Entry $15.93 to $19.23 Now $12.92 −18.90% ▲ +20.72% +18.18% vs SPY
  5. Jun 23, 202620w ago 8-K Neutral 4/10 Entry $14.73 to $21.03 Now $12.92 −12.29% ▲ +42.77% +39.93% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Bearish 4/10 Entry $14.72 to $21.04 Now $12.92 +12.23% ▼ −42.93% −39.67% vs SPY
  7. Jun 8, 202623w ago DEFA14A Neutral 4/10 Entry $14.60 to $21.11 Now $12.92 −11.51% ▲ +44.59% +41.54% vs SPY
  8. Jun 1, 202624w ago DEFA14A Neutral 3/10 Entry $14.63 to $21.40 Now $12.92 −11.69% ▲ +46.27% +45.04% vs SPY
  9. Apr 30, 202628w ago Insider Cluster Mixed 5/10 Entry $14.85 to $16.17 Now $12.92 −13.00% ▲ +8.89% +7.41% vs SPY
  10. Apr 29, 202628w ago 8-K Mixed 6/10 Entry $12.39 to $14.95 Now $12.92 +4.28% ▲ +20.66% +16.55% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 5h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 14, 2026